Clinical Trial Update: Russian Kogenate Pediatric Study [Phase 4]

View source ↗

Summary

Phase 4 pediatric trial update for Kogenate in Hemophilia A; results have been posted following completion of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Kogenate (recombinant antihemophilic factor (factor VIII))

Snippet

Sponsor: Bayer | Conditions: Hemophilia A | Phase 4 | Status: COMPLETED | Results posted: 2011-02-08